Full View

Association between antipsychotic polypharmacy and outcomes for people with serious mental illness in England

P Kasteridis, J Ride, N Gutacker, L Aylott… - Psychiatric …, 2019 - Am Psychiatric Assoc
Objective: Although UK and international guidelines recommend monotherapy,
antipsychotic polypharmacy among patients with serious mental illness is common in clinical …
被引用次数：30 相关文章

Association between antipsychotic polypharmacy and outcomes for people with serious mental illness in England.

P Kasteridis, J Ride, N Gutacker, L Aylott… - Psychiatric …, 2019 - psycnet.apa.org
Objective: Although UK and international guidelines recommend monotherapy,
antipsychotic polypharmacy among patients with serious mental illness is common in clinical …
[PDF] unimelb.edu.au

[PDF][PDF] Association between antipsychotic polypharmacy and outcomes for people with serious mental illness in England

P Kasteridisa, J Ridea, N Gutackera, L Aylottb, C Dareb… - minerva-access.unimelb.edu.au
Objective Although UK and international guidelines recommend monotherapy, antipsychotic
polypharmacy in people with serious mental illness is common in clinical practice. However …

Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England.

P Kasteridis, J Ride, N Gutacker, L Aylott… - Psychiatric Services …, 2019 - europepmc.org
Objective Although UK and international guidelines recommend monotherapy, antipsychotic
polypharmacy among patients with serious mental illness is common in clinical practice …

Association between antipsychotic polypharmacy and outcomes for people with serious mental illness in England

P Kasteridis, J Ride, N Gutacker, L Aylott… - Psychiatric …, 2019 - research.monash.edu
Objective: Although UK and international guidelines recommend monotherapy,
antipsychotic polypharmacy among patients with serious mental illness is common in clinical …

Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England

P Kasteridis, J Ride, N Gutacker, L Aylott… - Psychiatric services …, 2019 - pure.york.ac.uk
OBJECTIVE: Although UK and international guidelines recommend monotherapy,
antipsychotic polypharmacy among patients with serious mental illness is common in clinical …
[HTML] nih.gov

[HTML][HTML] Association between antipsychotic polypharmacy and outcomes for people with serious mental illness in England

P Kasteridis, J Ride, N Gutacker, L Aylott… - Psychiatric services …, 2019 - ncbi.nlm.nih.gov
Objective Although UK and international guidelines recommend monotherapy, antipsychotic
polypharmacy in people with serious mental illness is common in clinical practice. However …

Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England

P Kasteridis, J Ride, N Gutacker… - Psychiatric services …, 2019 - eprints.whiterose.ac.uk
OBJECTIVE: Although UK and international guidelines recommend monotherapy,
antipsychotic polypharmacy among patients with serious mental illness is common in clinical …

Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England

P Kasteridis, J Ride, N Gutacker… - Psychiatric …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective Although UK and international guidelines recommend monotherapy, antipsychotic
polypharmacy among patients with serious mental illness is common in clinical practice …

Association between antipsychotic polypharmacy and outcomes for people with serious mental illness in England

P Kasteridis, J Ride, N Gutaker, L Aylott… - Psychiatric …, 2019 - eprints.soton.ac.uk
Objective: Although UK and international guidelines recommend monotherapy,
antipsychotic polypharmacy among patients with serious mental illness is common in clinical …